Zoetis Inc. (NYSE: ZTS) AI-Powered Stock Analysis
See how Zoetis Inc. scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
ZTS●NYSE
HealthcareDrug Manufacturers - General
$74.83
$2.17(2.99%)
U.S. Market opens in 1h 35m
Zoetis Inc. (NYSE: ZTS) AI-Powered Stock Analysis
See how Zoetis Inc. scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerZoetis Inc. (NYSE: ZTS) Stock Overall Grade
Zoetis Inc.'s grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Zoetis Inc.'s overall NYSE stock rating.
Forecast
B+Score
78/100Financial Growth
A+Score
100/100Fundamental Growth
AScore
85/100Key Ratios
A+Score
97/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Zoetis Inc. (NYSE: ZTS) AI-Powered Stock Analysis
On the NYSE, ZTS demonstrates Good performance with an overall Forecast Score of 78/100 (B+), reflecting high confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (85/100, A) highlight its stability, while Key Ratios (97/100, A+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NYSE: ZTS) Component Analysis Explained
Understand the key factors behind each Zoetis Inc. (NYSE: ZTS) stock grade, including financials, comparisons, and forecasts.